# Beam Therapeutics Inc. (BEAM): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/beam for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta thalassemia. BEAM-102 is specifically designed for addressing sickle cell disease. BEAM-201, an allogeneic chimeric antigen receptor T-cell therapy, is under investigation for indivi...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $24.05 USD |
| Market Cap | $2.48B |
| P/E (TTM) | — |
| EPS (TTM) | −$3.29 |
| 52-Week Range | $20.23 – $38.26 |
| Dividend Yield (TTM) | — |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | — |
| Annual Dividend (TTM) | — /share |
| Annual Dividend (Forward) | — /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 7.1% / — / — / — |
| Payout Ratio (EPS, TTM) | — |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | — |
| Payout Ratio (FCF, forward dividend) | — |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2013-11-04 | $0.2250 | 2013-12-02 |
| 2013-08-12 | $0.2250 | 2013-09-03 |
| 2013-05-06 | $0.2250 | 2013-06-03 |
| 2013-02-04 | $0.2250 | 2013-03-01 |
| 2012-02-06 | $0.2100 | 2012-03-01 |

Full history: https://www.dividenddata.com/stocks/beam/dividend

## Frequently Asked Questions

### What does Beam Therapeutics Inc. do?

Beam Therapeutics Inc. (BEAM) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is BEAM's market cap?

Beam Therapeutics Inc. (BEAM) has a market capitalization of approximately $2.48 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does BEAM pay a dividend?

No, Beam Therapeutics Inc. (BEAM) is not currently paying a dividend. Its last ex-dividend date was November 4, 2013 ($0.23 per share), and no payment has been declared since. The full historical payment record is on the Dividend tab.

### Is BEAM profitable?

Beam Therapeutics Inc. (BEAM) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### How often did BEAM pay dividends?

Beam Therapeutics Inc. paid dividends quarterly until 2013; nothing has been declared since. Each historical ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is BEAM's payout ratio?

Beam Therapeutics Inc.'s payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/beam
- Dividend history & safety: https://www.dividenddata.com/stocks/beam/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/beam/earnings
- Financial statements: https://www.dividenddata.com/stocks/beam/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/beam/valuation
- Peer comparison: https://www.dividenddata.com/stocks/beam/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.